This old version of Proteopedia is provided for student assignments while the new version is undergoing repairs. Content and edits done in this old version of Proteopedia after March 1, 2026 will eventually be lost when it is retired in about June of 2026.
Apply for new accounts at the new Proteopedia. Your logins will work in both the old and new versions.
7dls
From Proteopedia
(Difference between revisions)
| Line 1: | Line 1: | ||
==Cytochrome P450 (CYP105D18) complex with papaverine== | ==Cytochrome P450 (CYP105D18) complex with papaverine== | ||
| - | <StructureSection load='7dls' size='340' side='right'caption='[[7dls]]' scene=''> | + | <StructureSection load='7dls' size='340' side='right'caption='[[7dls]], [[Resolution|resolution]] 2.06Å' scene=''> |
== Structural highlights == | == Structural highlights == | ||
| - | <table><tr><td colspan='2'>Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=7DLS OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=7DLS FirstGlance]. <br> | + | <table><tr><td colspan='2'>[[7dls]] is a 1 chain structure with sequence from [https://en.wikipedia.org/wiki/Atcc_31255 Atcc 31255]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=7DLS OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=7DLS FirstGlance]. <br> |
| - | </td></tr><tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=7dls FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=7dls OCA], [https://pdbe.org/7dls PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=7dls RCSB], [https://www.ebi.ac.uk/pdbsum/7dls PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=7dls ProSAT]</span></td></tr> | + | </td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=EV1:1-(3,4-DIMETHOXYBENZYL)-6,7-DIMETHOXYISOQUINOLINE'>EV1</scene>, <scene name='pdbligand=HEM:PROTOPORPHYRIN+IX+CONTAINING+FE'>HEM</scene></td></tr> |
| + | <tr id='related'><td class="sblockLbl"><b>[[Related_structure|Related:]]</b></td><td class="sblockDat"><div style='overflow: auto; max-height: 3em;'>[[7di3|7di3]]</div></td></tr> | ||
| + | <tr id='gene'><td class="sblockLbl"><b>[[Gene|Gene:]]</b></td><td class="sblockDat">SLA_5925 ([https://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?mode=Info&srchmode=5&id=39478 ATCC 31255])</td></tr> | ||
| + | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=7dls FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=7dls OCA], [https://pdbe.org/7dls PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=7dls RCSB], [https://www.ebi.ac.uk/pdbsum/7dls PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=7dls ProSAT]</span></td></tr> | ||
</table> | </table> | ||
| + | <div style="background-color:#fffaf0;"> | ||
| + | == Publication Abstract from PubMed == | ||
| + | The bacterial CYP105 family is involved in secondary metabolite biosynthetic pathways and plays essential roles in the biotransformation of xenobiotics. This study investigates the newly identified H2O2-mediated CYP105D18 from Streptomyces laurentii as the first bacterial CYP for N-oxidation. The catalytic efficiency of CYP105D18 for papaverine N-oxidation was 1.43 s(-1) microM (-1). The heme oxidation rate (k) was low (<0.3 min(-1)) in the presence of 200 mM H2O2. This high H2O2 tolerance capacity of CYP105D18 led to higher turnover prior to heme oxidation. Additionally, the high-resolution papaverine complexed structure and substrate-free structure of CYP105D18 were determined. Structural analysis and activity assay results revealed that CYP105D18 had a strong substrate preference for papaverine because of its bendable structure. These findings establish a basis for biotechnological applications of CYP105D18 in the pharmaceutical and medicinal industries. | ||
| + | |||
| + | Characterization of high-H2O2-tolerant bacterial cytochrome P450 CYP105D18: insights into papaverine N-oxidation.,Pardhe BD, Do H, Jeong CS, Kim KH, Lee JH, Oh TJ IUCrJ. 2021 Jun 29;8(Pt 4):684-694. doi: 10.1107/S2052252521005522. eCollection, 2021 Jul 1. PMID:34258016<ref>PMID:34258016</ref> | ||
| + | |||
| + | From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.<br> | ||
| + | </div> | ||
| + | <div class="pdbe-citations 7dls" style="background-color:#fffaf0;"></div> | ||
| + | == References == | ||
| + | <references/> | ||
__TOC__ | __TOC__ | ||
</StructureSection> | </StructureSection> | ||
| + | [[Category: Atcc 31255]] | ||
[[Category: Large Structures]] | [[Category: Large Structures]] | ||
| - | [[Category: Do H]] | + | [[Category: Do, H]] |
| - | [[Category: Lee | + | [[Category: Lee, J H]] |
| + | [[Category: Chemical modification]] | ||
| + | [[Category: Eukaryotic cytochrome p450]] | ||
| + | [[Category: Heme oxidation]] | ||
| + | [[Category: Papaverine n-oxide]] | ||
| + | [[Category: Transferase]] | ||
Revision as of 10:47, 28 July 2021
Cytochrome P450 (CYP105D18) complex with papaverine
| |||||||||||
